CiRA has offered iPS cell stocks since 2013. The Kyoto University-based research institute has now decided to rely on back-ups from Takara Bio, with a proven track record for industrial iPS-based cell preparations, to strengthen manufacturing control of the four cordd blood-deirved iPS cells manufactured by CiRA.

Takara Bio news release, January 24, 2017